Arecor Therapeutics plc (AREC.L)
AREC.L Stock Price Chart
Explore Arecor Therapeutics plc interactive price chart. Choose custom timeframes to analyze AREC.L price movements and trends.
AREC.L Company Profile
Discover essential business fundamentals and corporate details for Arecor Therapeutics plc (AREC.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Jun 2021
Employees
50.00
Website
https://www.arecor.comCEO
Sarah Jennifer Howell
Description
Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
AREC.L Financial Timeline
Browse a chronological timeline of Arecor Therapeutics plc corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 Apr 2025
EPS came in at -£0.15, while revenue for the quarter reached £3.06M.
Earnings released on 26 Sept 2024
EPS came in at -£0.15, while revenue for the quarter reached £2.00M.
Earnings released on 16 May 2024
EPS came in at -£0.13, while revenue for the quarter reached £2.90M.
Earnings released on 14 Sept 2023
EPS came in at -£0.15, while revenue for the quarter reached £1.67M.
Earnings released on 20 Apr 2023
EPS came in at -£0.16, while revenue for the quarter reached £1.71M.
Earnings released on 8 Sept 2022
EPS came in at -£0.16, while revenue for the quarter reached £693.00K.
Earnings released on 25 Apr 2022
EPS came in at -£0.11, while revenue for the quarter reached £697.98K.
Earnings released on 23 Sept 2021
EPS came in at -£0.11, while revenue for the quarter reached £460.02K.
Earnings released on 31 Dec 2020
EPS came in at -£0.06, while revenue for the quarter reached £880.96K.
AREC.L Stock Performance
Access detailed AREC.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.